Correlation Between Neogen and Aclaris Therapeutics

Can any of the company-specific risk be diversified away by investing in both Neogen and Aclaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neogen and Aclaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neogen and Aclaris Therapeutics, you can compare the effects of market volatilities on Neogen and Aclaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neogen with a short position of Aclaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neogen and Aclaris Therapeutics.

Diversification Opportunities for Neogen and Aclaris Therapeutics

-0.67

Correlation Coefficient

Neogen  Aclaris Therapeutics

Excellent diversification

The 3 months correlation between Neogen and Aclaris is -0.67. Overlapping area represents the amount of risk that can be diversified away by holding Neogen and Aclaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aclaris Therapeutics and Neogen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neogen are associated (or correlated) with Aclaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aclaris Therapeutics has no effect on the direction of Neogen i.e., Neogen and Aclaris Therapeutics go up and down completely randomly.

Pair Corralation between Neogen and Aclaris Therapeutics

Given the investment horizon of 90 days Neogen is expected to under-perform the Aclaris Therapeutics. In addition to that, Neogen is 1.3 times more volatile than Aclaris Therapeutics. It trades about -0.07 of its total potential returns per unit of risk. Aclaris Therapeutics is currently generating about 0.09 per unit of volatility. If you would invest  146.00  in Aclaris Therapeutics on May 6, 2025 and sell it today you would earn a total of  7.00  from holding Aclaris Therapeutics or generate 4.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Neogen  vs.  Aclaris Therapeutics

Neogen

Risk-Adjusted Performance

Very Weak

Over the last 90 days Neogen has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest unsteady performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Aclaris Therapeutics

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Aclaris Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Aclaris Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neogen and Aclaris Therapeutics

The main advantage of trading using opposite Neogen and Aclaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neogen position performs unexpectedly, Aclaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aclaris Therapeutics will offset losses from the drop in Aclaris Therapeutics' long position.

The idea behind Neogen and Aclaris Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.